Pilot study evaluating everolimus molecular mechanisms in tuberous sclerosis complex and focal cortical dysplasia is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0.907. It has been cited 23 times, with 17 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.477
From this paper's citation signal
Citation Network Contribution
0.430
From 13 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 17 citers.
National Institutes of Health
Grant: P01AG060882
NIA NIH HHS
Grant: P30 AG066512
National Institutes of Health
Grant: 5P01AG060882-02
Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease
Novartis
Finding A Cure for Epilepsy and Seizures
FWCI
2.53
Citation Percentile
0.9%
Influential Citations
2
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals